Advancements in mesenchymal stem cell (MSC) research and therapy are shedding light on how these stem cells may someday be used in various clinical applications such as immunomodulatory therapies and in cell replacement therapies for mesenchymal tissues such as bone and cartilage. We offer an extensive selection of specialty products optimized for mesenchymal stem cell populations.
From pluripotent stem cell (PSC) to terminally differentiated cells in as little as 3 to 6 weeks. Provide your own cells or have us reprogram somatic cells into PSCs.
Let us confirm stem cell identity, pluripotency, gene expression, and other characteristics of stem cells.
Our stem cell research products have been an integral part of Induced Pluripotent Stem Cells research from the initial discovery of iPSCs to current breakthroughs. Our broad technology platform provides optimized tools for each step of the stem cell workflow: from reprogramming somatic cells to iPSC expansion, validation, and differentiation.
Stem cell therapy offers promising advancements in treating liver diseases in newborns. By utilizing the regenerative capabilities of stem cells, researchers aim to repair or replace damaged liver tissue, potentially alleviating the severe consequences associated with these conditions.
Toxic cholestasis, a severe liver disease, can be treated with stem cells. Stem cells have the potential to differentiate into hepatocytes, the main functional cells of the liver, and contribute to liver regeneration and repair. Preclinical studies have shown promising results, suggesting that stem cell therapy may offer a novel therapeutic approach for toxic cholestasis.
Fibrotic liver changes, characterized by excessive collagen deposition and impaired liver function, can be potentially treated with stem cell therapy. Stem cells possess regenerative and antifibrotic properties, offering a promising therapeutic approach to restore liver function and mitigate fibrosis.